Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

Computerized Dynamic Posturography for Diagnosis of Vestibular Disorders

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of computerized dynamic posturography (CDP) for diagnosing vestibular disorders in adults with signs and symptoms suggesting vestibular disorder, compared with standard otoneurologic tests. While other Hayes reports have more b…

Barostim Neo System (CVRx Inc.) for Treatment of Heart Failure

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Barostim Neo System (CVRx Inc.) for the treatment of heart failure (HF) to improve quality of life (QOL) and functional outcomes.

Proton Beam Therapy for Esophageal Squamous Cell Carcinoma

Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of proton beam therapy (PBT) compared with conventional (photon-based) external beam radiation therapies to treat esophageal squamous cell carcinoma (ESCC) in adults.

Technolo…

Proton Beam Therapy for Esophageal Adenocarcinoma

Focus of the Report: The focus of this Health Technology Assessment (HTA) is the evaluation of the effectiveness and safety of proton beam therapy (PBT) compared with conventional (photon-based) external beam radiation therapies for the treatment of esophageal adenocarcinoma (EAC) in adults.

Proton Beam Therapy for Treatment of Breast Cancer

Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the safety and effectiveness of proton beam therapy (PBT) for the treatment of breast cancer with no distant metastasis. This HTA also compares the safety and effectiveness of PBT with conventional radiation therapies.